19 results on '"Lun Li"'
Search Results
2. The Global Research Collaboration of Network Meta-Analysis: A Social Network Analysis.
- Author
-
Lun Li, Ferrán Catalá-López, Adolfo Alonso-Arroyo, Jinhui Tian, Rafael Aleixandre-Benavent, Dawid Pieper, Long Ge, Liang Yao, Quan Wang, and Kehu Yang
- Subjects
Medicine ,Science - Abstract
BACKGROUND AND OBJECTIVE:Research collaborations in biomedical research have evolved over time. No studies have addressed research collaboration in network meta-analysis (NMA). In this study, we used social network analysis methods to characterize global collaboration patterns of published NMAs over the past decades. METHODS:PubMed, EMBASE, Web of Science and the Cochrane Library were searched (at 9th July, 2015) to include systematic reviews incorporating NMA. Two reviewers independently selected studies and cross-checked the standardized data. Data was analyzed using Ucinet 6.0 and SPSS 17.0. NetDraw software was used to draw social networks. RESULTS:771 NMAs published in 336 journals from 3459 authors and 1258 institutions in 49 countries through the period 1997-2015 were included. More than three-quarters (n = 625; 81.06%) of the NMAs were published in the last 5-years. The BMJ (4.93%), Current Medical Research and Opinion (4.67%) and PLOS One (4.02%) were the journals that published the greatest number of NMAs. The UK and the USA (followed by Canada, China, the Netherlands, Italy and Germany) headed the absolute global productivity ranking in number of NMAs. The top 20 authors and institutions with the highest publication rates were identified. Overall, 43 clusters of authors (four major groups: one with 37 members, one with 12 members, one with 11 members and one with 10 members) and 21 clusters of institutions (two major groups: one with 62 members and one with 20 members) were identified. The most prolific authors were affiliated with academic institutions and private consulting firms. 181 consulting firms and pharmaceutical industries (14.39% of institutions) were involved in 199 NMAs (25.81% of total publications). Although there were increases in international and inter-institution collaborations, the research collaboration by authors, institutions and countries were still weak and most collaboration groups were small sizes. CONCLUSION:Scientific production on NMA is increasing worldwide with research leadership of Western countries (most notably, the UK, the USA and Canada). More authors, institutions and nations are becoming involved in research collaborations, but frequently with limited international collaborations.
- Published
- 2016
- Full Text
- View/download PDF
3. Genome wide analysis of flowering time trait in multiple environments via high-throughput genotyping technique in Brassica napus L.
- Author
-
Lun Li, Yan Long, Libin Zhang, Jessica Dalton-Morgan, Jacqueline Batley, Longjiang Yu, Jinling Meng, and Maoteng Li
- Subjects
Medicine ,Science - Abstract
The prediction of the flowering time (FT) trait in Brassica napus based on genome-wide markers and the detection of underlying genetic factors is important not only for oilseed producers around the world but also for the other crop industry in the rotation system in China. In previous studies the low density and mixture of biomarkers used obstructed genomic selection in B. napus and comprehensive mapping of FT related loci. In this study, a high-density genome-wide SNP set was genotyped from a double-haploid population of B. napus. We first performed genomic prediction of FT traits in B. napus using SNPs across the genome under ten environments of three geographic regions via eight existing genomic predictive models. The results showed that all the models achieved comparably high accuracies, verifying the feasibility of genomic prediction in B. napus. Next, we performed a large-scale mapping of FT related loci among three regions, and found 437 associated SNPs, some of which represented known FT genes, such as AP1 and PHYE. The genes tagged by the associated SNPs were enriched in biological processes involved in the formation of flowers. Epistasis analysis showed that significant interactions were found between detected loci, even among some known FT related genes. All the results showed that our large scale and high-density genotype data are of great practical and scientific values for B. napus. To our best knowledge, this is the first evaluation of genomic selection models in B. napus based on a high-density SNP dataset and large-scale mapping of FT loci.
- Published
- 2015
- Full Text
- View/download PDF
4. Regulation of monocarboxylic acid transporter-1 by cAMP dependent vesicular trafficking in brain microvascular endothelial cells.
- Author
-
Amy L Uhernik, Lun Li, Nathan LaVoy, Micah J Velasquez, and Jeffrey P Smith
- Subjects
Medicine ,Science - Abstract
In this study, a detailed characterization of Monocarboxylic Acid Transporter-1 (Mct1) in cytoplasmic vesicles of cultured rat brain microvascular endothelial cells shows them to be a diverse population of endosomes intrinsic to the regulation of the transporter by a brief 25 to 30 minute exposure to the membrane permeant cAMP analog, 8Br-cAMP. The vesicles are heterogeneous in size, mobility, internal pH, and co-localize with discreet markers of particular types of endosomes including early endosomes, clathrin coated vesicles, caveolar vesicles, trans-golgi, and lysosomes. The vesicular localization of Mct1 was not dependent on its N or C termini, however, the size and pH of Mct1 vesicles was increased by deletion of either terminus demonstrating a role for the termini in vesicular trafficking of Mct1. Using a novel BCECF-AM based assay developed in this study, 8Br-cAMP was shown to decrease the pH of Mct1 vesicles after 25 minutes. This result and method were confirmed in experiments with a ratiometric pH-sensitive EGFP-mCherry dual tagged Mct1 construct. Overall, the results indicate that cAMP signaling reduces the functionality of Mct1 in cerebrovascular endothelial cells by facilitating its entry into a highly dynamic vesicular trafficking pathway that appears to lead to the transporter's trafficking to autophagosomes and lysosomes.
- Published
- 2014
- Full Text
- View/download PDF
5. The efficacy and safety of different kinds of laparoscopic cholecystectomy: a network meta analysis of 43 randomized controlled trials.
- Author
-
Lun Li, Jinhui Tian, Hongliang Tian, Rao Sun, Quan Wang, and Kehu Yang
- Subjects
Medicine ,Science - Abstract
BACKGROUND AND OBJECTIVE: We conducted a network meta analysis (NMA) to compare different kinds of laparoscopic cholecystectomy [LC] (single port [SPLC], two ports [2PLC], three ports [3PLC], and four ports laparoscopic cholecystectomy [4PLC], and four ports mini-laparoscopic cholecystectomy [mini-4PLC]). METHODS: PubMed, the Cochrane library, EMBASE, and ISI Web of Knowledge were searched to find randomized controlled trials [RCTs]. Direct pair-wise meta analysis (DMA), indirect treatment comparison meta analysis (ITC) and NMA were conducted to compare different kinds of LC. RESULTS: We included 43 RCTs. The risk of bias of included studies was high. DMA showed that SPLC was associated with more postoperative complications, longer operative time, and higher cosmetic score than 4PLC, longer operative time and higher cosmetic score than 3PLC, more postoperative complications than mini-4PLC. Mini-4PLC was associated with longer operative time than 4PLC. ITC showed that 3PLC was associated with shorter operative time than mini-4PLC, and lower postoperative pain level than 2PLC. 2PLC was associated with fewer postoperative complications and longer hospital stay than SPLC. NMA showed that SPLC was associated with more postoperative complications than mini-4PLC, and longer operative time than 4PLC. CONCLUSION: The rank probability plot suggested 4PLC might be the worst due to the highest level of postoperative pain, longest hospital stay, and lowest level of cosmetic score. The best one might be mini-4PLC because of highest level of cosmetic score, and fewest postoperative complications, or SPLC because of lowest level of postoperative pain and shortest hospital stay. But more studies are needed to determine which will be better between mini-4PLC and SPLC.
- Published
- 2014
- Full Text
- View/download PDF
6. A randomized, single-center double-blinded trial on the effects of diltiazem sustained-release capsules in patients with coronary slow flow phenomenon at 6-month follow-up.
- Author
-
Lun Li, Ye Gu, Tao Liu, Yupeng Bai, Lingbo Hou, Zhong Cheng, Liqun Hu, and Bo Gao
- Subjects
Medicine ,Science - Abstract
OBJECTIVE: The aim of this study is to observe the chronic effects of diltiazem release capsules on patients with coronary slow flow (CSF) phenomenon. METHODS: From 2004 to 2009, 80 consecutive patients with chest pain and normal coronary arteries evidenced by coronary angiography and CSF were included in this randomized, double-blind, placebo-controlled trial. CSF patterns were evaluated by the corrected TIMI frame count. Patients were randomly assigned at 1:1 ratio to diltiazem sustained-release capsules treatment group (Dil, 90 mg twice daily) or placebo control group. Holter, liver and kidney function, treadmill exercise test, coronary angiography and left ventricular angiography were measured at baseline and after 6 months. The incidence of cardiovascular events (re-admission or progress in coronary heart disease, myocardial infarction, malignant arrhythmia or cardiac death) was evaluated during the 6 months follow up. RESULTS: Thirty-nine patients in control and 40 patients in Dil group completed the 6 months follow-up. There was no medication induced drug withdraw during follow up. Left ventricular ejection fraction was similar between the 2 groups at baseline and during follow up. Heart rate was significantly lower in Dil group than in control group and there was no symptomatic bradycardia and II and III degree atrioventricular conduction block in both groups. Significant improvement was observed in the onset of chest pain, treadmill exercise test and coronary blood flow in Dil group while these parameters remained unchanged in control group at the end of 6 months follow up. The incidence of cardiovascular events was similar between the two groups. CONCLUSION: Diltiazem slow-release capsules improved coronary blood flow and alleviated angina in patients with CSF. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR-TCC-11001864.
- Published
- 2012
- Full Text
- View/download PDF
7. Application of GFAT as a novel selection marker to mediate gene expression.
- Author
-
Guogan Wu, Yu Sun, Wei Qu, Ying Huang, Ling Lu, Lun Li, and Weilan Shao
- Subjects
Medicine ,Science - Abstract
The enzyme glutamine: fructose-6-phosphate aminotransferase (GFAT), also known as glucosamine synthase (GlmS), catalyzes the formation of glucosamine-6-phosphate from fructose-6-phosphate and is the first and rate-limiting enzyme of the hexosamine biosynthetic pathway. For the first time, the GFAT gene was proven to possess a function as an effective selection marker for genetically modified (GM) microorganisms. This was shown by construction and analysis of two GFAT deficient strains, E. coli ΔglmS and S. pombe Δgfa1, and the ability of the GFAT encoding gene to mediate plasmid selection. The gfa1 gene of the fission yeast Schizosaccharomyces pombe was deleted by KanMX6-mediated gene disruption and the Cre-loxP marker removal system, and the glmS gene of Escherichia coli was deleted by using λ-Red mediated recombinase system. Both E. coli ΔglmS and S. pombe Δgfa1 could not grow normally in the media without addition of glucosamine. However, the deficiency was complemented by transforming the plasmids that expressed GFAT genes. The xylanase encoding gene, xynA2 from Thermomyces lanuginosus was successfully expressed and secreted by using GFAT as selection marker in S. pombe. Optimal glucosamine concentration for E. coli ΔglmS and S. pombe Δgfa1 growth was determined respectively. These findings provide an effective technique for the construction of GM bacteria without an antibiotic resistant marker, and the construction of GM yeasts to be applied to complex media.
- Published
- 2011
- Full Text
- View/download PDF
8. Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout
- Author
-
Hsin-Lun Li, Chii-Min Hwu, James Cheng-Chung Wei, Chih-Cheng Hsu, and Fu-Shun Yen
- Subjects
Male ,Gout ,Kaplan-Meier Estimate ,030204 cardiovascular system & hematology ,Vascular Medicine ,Cohort Studies ,0302 clinical medicine ,Epidemiology ,Medicine and Health Sciences ,Coronary Heart Disease ,Hyperuricemia ,Hospital Mortality ,Diuretics ,Stroke ,education.field_of_study ,Multidisciplinary ,Incidence (epidemiology) ,Hazard ratio ,Drugs ,Middle Aged ,Hospitalization ,Treatment Outcome ,Neurology ,Research Design ,Medicine ,Female ,Research Article ,Adult ,medicine.medical_specialty ,Death Rates ,Science ,Cerebrovascular Diseases ,Inflammatory Diseases ,Allopurinol ,Population ,Cardiology ,Taiwan ,Research and Analysis Methods ,Risk Assessment ,Gout Suppressants ,03 medical and health sciences ,Young Adult ,Rheumatology ,Population Metrics ,Internal medicine ,medicine ,Humans ,education ,Ischemic Stroke ,Aged ,Retrospective Studies ,030203 arthritis & rheumatology ,Heart Failure ,Pharmacology ,Population Biology ,business.industry ,Biology and Life Sciences ,Retrospective cohort study ,medicine.disease ,Uric Acid ,business - Abstract
ObjectivesAlthough studies have demonstrated the association of hyperuricemia with cardiovascular (CV) diseases, few have explored the effect of urate-lowering therapy (ULT) on the incidence of CV diseases. Therefore, we compared the risks of hospitalized coronary artery disease (CAD), stroke, heart failure (HF), and all-cause mortality between ULT users and nonusers among patients with gout.MethodsWe performed this retrospective cohort study using Taiwan's population-based National Health Insurance Research Database. In total, 5218 patients with gout were included from 2000 to 2012. We compared the incidence rates (IRs) of hospitalized CAD, stroke, HF, and all-cause mortality between ULT users and matched nonusers.ResultsThe IRs of hospitalized stroke were 0.6 and 1.0 per 100 person-years for ULT users and nonusers, respectively, after adjusting for age, sex, residence, comorbidities, and medications. ULT users showed lower adjusted hazard ratios (aHR) for hospitalized stroke (aHR: 0.52, p < 0.001) and all-cause mortality (aHR: 0.6, p = 0.02) than nonusers. Subgroup analyses revealed that uricosuric agents and xanthine oxidase inhibitors were significantly associated with lower risks of hospitalized stroke and all-cause mortality, respectively. The effect of uricosuric agents on the decrease in hospitalized stroke risk indicated a dose-response relationship.ConclusionsOur study showed lower risks of hospitalized stroke and all-cause mortality in ULT users than in nonusers among patients with gout. Therefore, patients with gout may receive ULT to mitigate the risks of hospitalized stroke and mortality.
- Published
- 2020
9. A single-center randomized controlled trial observing the safety and efficacy of modified step-up graded Valsalva manoeuver in patients with vasovagal syncope
- Author
-
Li He, Huan-Huan Li, Lun Li, Ye Gu, Lan Wang, Yijun Yu, Xiaoyun Zeng, and Xiaoyan Liu
- Subjects
Male ,medicine.medical_treatment ,lcsh:Medicine ,Blood Pressure ,030204 cardiovascular system & hematology ,Single Center ,Pathology and Laboratory Medicine ,Vascular Medicine ,law.invention ,Tilt table test ,0302 clinical medicine ,Randomized controlled trial ,law ,Tilt-Table Test ,Heart Rate ,Valsalva maneuver ,Syncope, Vasovagal ,Medicine and Health Sciences ,lcsh:Science ,Aged, 80 and over ,Multidisciplinary ,medicine.diagnostic_test ,Pharmaceutics ,Incidence (epidemiology) ,Hematology ,Middle Aged ,Cardiology ,Female ,Calcium Antagonist Therapy ,Research Article ,Adult ,medicine.medical_specialty ,Drug Research and Development ,Adolescent ,Patients ,Valsalva Maneuver ,Research and Analysis Methods ,Syncope ,03 medical and health sciences ,Young Adult ,Signs and Symptoms ,Drug Therapy ,Diagnostic Medicine ,Internal medicine ,medicine ,Humans ,Clinical Trials ,Risk factor ,Vasovagal syncope ,Aged ,Pharmacology ,business.industry ,Proportional hazards model ,lcsh:R ,Hemodynamics ,medicine.disease ,Health Care ,lcsh:Q ,Clinical Medicine ,business ,030217 neurology & neurosurgery ,Receptor Antagonist Therapy - Abstract
Non-pharmacological therapies, especially the physical maneuvers, are viewed as important and promising strategies for reducing syncope recurrences in vasovagal syncope (VVS) patients. We observed the efficacy of a modified Valsalva maneuver (MVM) in VVS patients. 72 VVS patients with syncope history and positive head-up tilt table testing (HUTT) results were randomly divided into conventional treatment group (NVM group, n = 36) and conventional treatment plus standard MVM for 30 days group (MVM group, n = 36). Incidence of recurrent syncope after 12 months (6.5% vs. 41.2%, P
- Published
- 2017
10. Genome wide analysis of flowering time trait in multiple environments via high-throughput genotyping technique in Brassica napus L
- Author
-
Longjiang Yu, Jinling Meng, Yan Long, Jessica Dalton-Morgan, Jacqueline Batley, Libin Zhang, Lun Li, and Maoteng Li
- Subjects
Rapeseed ,Genotype ,Genotyping Techniques ,Genetic Linkage ,Science ,Quantitative Trait Loci ,Population ,Epistasis and functional genomics ,Single-nucleotide polymorphism ,Flowers ,Quantitative trait locus ,Biology ,Polymorphism, Single Nucleotide ,Genome ,education ,Genetic Association Studies ,Genetics ,education.field_of_study ,Multidisciplinary ,Brassica napus ,Chromosome Mapping ,food and beverages ,High-Throughput Screening Assays ,Epistasis ,Medicine ,Genome, Plant ,Research Article - Abstract
The prediction of the flowering time (FT) trait in Brassica napus based on genome-wide markers and the detection of underlying genetic factors is important not only for oilseed producers around the world but also for the other crop industry in the rotation system in China. In previous studies the low density and mixture of biomarkers used obstructed genomic selection in B. napus and comprehensive mapping of FT related loci. In this study, a high-density genome-wide SNP set was genotyped from a double-haploid population of B. napus. We first performed genomic prediction of FT traits in B. napus using SNPs across the genome under ten environments of three geographic regions via eight existing genomic predictive models. The results showed that all the models achieved comparably high accuracies, verifying the feasibility of genomic prediction in B. napus. Next, we performed a large-scale mapping of FT related loci among three regions, and found 437 associated SNPs, some of which represented known FT genes, such as AP1 and PHYE. The genes tagged by the associated SNPs were enriched in biological processes involved in the formation of flowers. Epistasis analysis showed that significant interactions were found between detected loci, even among some known FT related genes. All the results showed that our large scale and high-density genotype data are of great practical and scientific values for B. napus. To our best knowledge, this is the first evaluation of genomic selection models in B. napus based on a high-density SNP dataset and large-scale mapping of FT loci.
- Published
- 2015
11. Comparing modelling approaches for the estimation of government intervention effects in COVID-19: Impact of voluntary behavior changes
- Author
-
Lun Liu, Zhu Zhang, Hui Wang, Shenhao Wang, Shengsheng Zhuang, and Jishan Duan
- Subjects
Medicine ,Science - Abstract
The efficacy of government interventions in epidemic has become a hot subject since the onset of COVID-19. There is however much variation in the results quantifying the effects of interventions, which is partly related to the varying modelling approaches employed by existing studies. Among the many factors affecting the modelling results, people’s voluntary behavior change is less examined yet likely to be widespread. This paper therefore aims to analyze how the choice of modelling approach, in particular how voluntary behavior change is accounted for, would affect the intervention effect estimation. We conduct the analysis by experimenting different modelling methods on a same data set composed of the 500 most infected U.S. counties. We compare the most frequently used methods from the two classes of modelling approaches, which are Bayesian hierarchical model from the class of computational approach and difference-in-difference from the class of natural experimental approach. We find that computational methods that do not account for voluntary behavior changes are likely to produce larger estimates of intervention effects as assumed. In contrast, natural experimental methods are more likely to extract the true effect of interventions by ruling out simultaneous behavior change. Among different difference-in-difference estimators, the two-way fixed effect estimator seems to be an efficient one. Our work can inform the methodological choice of future research on this topic, as well as more robust re-interpretation of existing works, to facilitate both future epidemic response plans and the science of public health.
- Published
- 2023
12. Regulation of monocarboxylic acid transporter-1 by cAMP dependent vesicular trafficking in brain microvascular endothelial cells
- Author
-
Lun Li, Micah J. Velasquez, Nathan LaVoy, Jeffrey P. Smith, and Amy L. Uhernik
- Subjects
Monocarboxylic Acid Transporters ,Vesicle fusion ,Endosome ,Science ,8-Bromo Cyclic Adenosine Monophosphate ,Endosomes ,Signal transduction ,Clathrin ,Second Messenger Systems ,Biochemistry ,Signaling Pathways ,Cell Line ,Transmembrane Transport Proteins ,Molecular cell biology ,Neurobiology of Disease and Regeneration ,Animals ,Transport Vesicles ,Biology ,Multidisciplinary ,biology ,Symporters ,Vesicle ,Brain ,Endothelial Cells ,Proteins ,Signaling cascades ,Transporter ,Transfection ,Hydrogen-Ion Concentration ,Cellular Structures ,cAMP signaling cascade ,Transport protein ,Cell biology ,Rats ,Protein Transport ,Subcellular Organelles ,Cytoplasm ,Microvessels ,biology.protein ,Medicine ,Molecular Neuroscience ,Research Article ,Neuroscience - Abstract
In this study, a detailed characterization of Monocarboxylic Acid Transporter-1 (Mct1) in cytoplasmic vesicles of cultured rat brain microvascular endothelial cells shows them to be a diverse population of endosomes intrinsic to the regulation of the transporter by a brief 25 to 30 minute exposure to the membrane permeant cAMP analog, 8Br-cAMP. The vesicles are heterogeneous in size, mobility, internal pH, and co-localize with discreet markers of particular types of endosomes including early endosomes, clathrin coated vesicles, caveolar vesicles, trans-golgi, and lysosomes. The vesicular localization of Mct1 was not dependent on its N or C termini, however, the size and pH of Mct1 vesicles was increased by deletion of either terminus demonstrating a role for the termini in vesicular trafficking of Mct1. Using a novel BCECF-AM based assay developed in this study, 8Br-cAMP was shown to decrease the pH of Mct1 vesicles after 25 minutes. This result and method were confirmed in experiments with a ratiometric pH-sensitive EGFP-mCherry dual tagged Mct1 construct. Overall, the results indicate that cAMP signaling reduces the functionality of Mct1 in cerebrovascular endothelial cells by facilitating its entry into a highly dynamic vesicular trafficking pathway that appears to lead to the transporter's trafficking to autophagosomes and lysosomes.
- Published
- 2013
13. The Global Research Collaboration of Network Meta-Analysis: A Social Network Analysis
- Author
-
Jinhui Tian, Rafael Aleixandre-Benavent, Ferrán Catalá-López, Adolfo Alonso-Arroyo, Lun Li, Long Ge, Quan Wang, Kehu Yang, Dawid Pieper, Liang Yao, and Generalitat Valenciana
- Subjects
Comparative Effectiveness Research ,Social Sciences ,lcsh:Medicine ,Cochrane Library ,Geographical locations ,Mathematical and Statistical Techniques ,0302 clinical medicine ,Sociology ,Medicine and Health Sciences ,Centrality ,030212 general & internal medicine ,Health Systems Strengthening ,lcsh:Science ,Social network analysis ,Multidisciplinary ,Research Assessment ,3. Good health ,Professions ,Systematic review ,Social Networks ,Research Design ,030220 oncology & carcinogenesis ,Meta-analysis ,Physical Sciences ,Network Analysis ,Statistics (Mathematics) ,Research Article ,Computer and Information Sciences ,Canada ,Systematic Reviews ,Clinical Research Design ,MEDLINE ,Library science ,Research and Analysis Methods ,03 medical and health sciences ,Political science ,Statistical Methods ,China ,Productivity ,Health Care Policy ,lcsh:R ,Health Care ,Ranking ,People and Places ,North America ,Scientists ,Population Groupings ,lcsh:Q ,Mathematics ,Meta-Analysis - Abstract
et al., [Background and Objective]: Research collaborations in biomedical research have evolved over time. No studies have addressed research collaboration in network meta-analysis (NMA). In this study, we used social network analysis methods to characterize global collaboration patterns of published NMAs over the past decades. [Methods]: PubMed, EMBASE, Web of Science and the Cochrane Library were searched (at 9 July, 2015) to include systematic reviews incorporating NMA. Two reviewers independently selected studies and cross-checked the standardized data. Data was analyzed using Ucinet 6.0 and SPSS 17.0. NetDraw software was used to draw social networks. [Results]: 771 NMAs published in 336 journals from 3459 authors and 1258 institutions in 49 countries through the period 1997-2015 were included. More than three-quarters (n = 625; 81.06%) of the NMAs were published in the last 5-years. The BMJ (4.93%), Current Medical Research and Opinion (4.67%) and PLOS One (4.02%) were the journals that published the greatest number of NMAs. The UK and the USA (followed by Canada, China, the Netherlands, Italy and Germany) headed the absolute global productivity ranking in number of NMAs. The top 20 authors and institutions with the highest publication rates were identified. Overall, 43 clusters of authors (four major groups: one with 37 members, one with 12 members, one with 11 members and one with 10 members) and 21 clusters of institutions (two major groups: one with 62 members and one with 20 members) were identified. The most prolific authors were affiliated with academic institutions and private consulting firms. 181 consulting firms and pharmaceutical industries (14.39% of institutions) were involved in 199 NMAs (25.81% of total publications). Although there were increases in international and inter-institution collaborations, the research collaboration by authors, institutions and countries were still weak and most collaboration groups were small sizes. [Conclusion]: Scientific production on NMA is increasing worldwide with research leadership of Western countries (most notably, the UK, the USA and Canada). More authors, institutions and nations are becoming involved in research collaborations, but frequently with limited international collaborations., Ferrán Catalá-López is partially supported by the Generalitat Valenciana (PROMETEOII/2015/021).
- Published
- 2016
14. A randomized, single-center double-blinded trial on the effects of diltiazem sustained-release capsules in patients with coronary slow flow phenomenon at 6-month follow-up
- Author
-
Bo Gao, Yupeng Bai, Lingbo Hou, Zhong Cheng, Lun Li, Tao Liu, Ye Gu, and Liqun Hu
- Subjects
Male ,Anatomy and Physiology ,Critical Care and Emergency Medicine ,Administration, Oral ,lcsh:Medicine ,Coronary Disease ,Coronary Artery Disease ,Coronary Angiography ,Kidney Function Tests ,Cardiovascular ,Single Center ,Cardiovascular System ,Ventricular Function, Left ,law.invention ,Diltiazem ,Liver Function Tests ,Randomized controlled trial ,Heart Rate ,law ,Myocardial infarction ,lcsh:Science ,Multidisciplinary ,Ejection fraction ,Middle Aged ,Angina ,Prognosis ,Interventional Cardiology ,Death ,Hospitalization ,medicine.anatomical_structure ,cardiovascular system ,Cardiology ,Medicine ,Female ,Blood Flow Velocity ,Research Article ,medicine.drug ,Drugs and Devices ,medicine.medical_specialty ,Clinical Research Design ,Capsules ,Cardiovascular Pharmacology ,Double-Blind Method ,Internal medicine ,Heart rate ,medicine ,Humans ,Clinical Trials ,Biology ,business.industry ,Acute Cardiovascular Problems ,lcsh:R ,Arrhythmias, Cardiac ,medicine.disease ,Coronary arteries ,No reflow phenomenon ,Exercise Test ,No-Reflow Phenomenon ,lcsh:Q ,business ,Follow-Up Studies - Abstract
OBJECTIVE: The aim of this study is to observe the chronic effects of diltiazem release capsules on patients with coronary slow flow (CSF) phenomenon. METHODS: From 2004 to 2009, 80 consecutive patients with chest pain and normal coronary arteries evidenced by coronary angiography and CSF were included in this randomized, double-blind, placebo-controlled trial. CSF patterns were evaluated by the corrected TIMI frame count. Patients were randomly assigned at 1:1 ratio to diltiazem sustained-release capsules treatment group (Dil, 90 mg twice daily) or placebo control group. Holter, liver and kidney function, treadmill exercise test, coronary angiography and left ventricular angiography were measured at baseline and after 6 months. The incidence of cardiovascular events (re-admission or progress in coronary heart disease, myocardial infarction, malignant arrhythmia or cardiac death) was evaluated during the 6 months follow up. RESULTS: Thirty-nine patients in control and 40 patients in Dil group completed the 6 months follow-up. There was no medication induced drug withdraw during follow up. Left ventricular ejection fraction was similar between the 2 groups at baseline and during follow up. Heart rate was significantly lower in Dil group than in control group and there was no symptomatic bradycardia and II and III degree atrioventricular conduction block in both groups. Significant improvement was observed in the onset of chest pain, treadmill exercise test and coronary blood flow in Dil group while these parameters remained unchanged in control group at the end of 6 months follow up. The incidence of cardiovascular events was similar between the two groups. CONCLUSION: Diltiazem slow-release capsules improved coronary blood flow and alleviated angina in patients with CSF. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR-TCC-11001864.
- Published
- 2012
15. MiR-142-3p Attenuates the Migration of CD4+ T Cells through Regulating Actin Cytoskeleton via RAC1 and ROCK2 in Arteriosclerosis Obliterans
- Author
-
Chunxiang Zhang, Jing-song Ou, Jiawei Liu, Yidan Wu, Zi-lun Li, Wen Li, Siwen Wang, Shenming Wang, Rui-Ming Liu, and Wenjian Wang
- Subjects
CD4-Positive T-Lymphocytes ,Male ,rac1 GTP-Binding Protein ,Cardiology ,lcsh:Medicine ,Biology ,CCL5 ,Mice ,Interleukin 21 ,Cell Movement ,Molecular Cell Biology ,Genetics ,Medicine and Health Sciences ,Animals ,Humans ,Cytotoxic T cell ,IL-2 receptor ,lcsh:Science ,Antigen-presenting cell ,Cells, Cultured ,In Situ Hybridization ,Aged ,rho-Associated Kinases ,Multidisciplinary ,ZAP70 ,lcsh:R ,Biology and Life Sciences ,Arteriosclerosis Obliterans ,Cell Biology ,Actin cytoskeleton ,Molecular biology ,Cell biology ,Actin Cytoskeleton ,MicroRNAs ,T cell migration ,lcsh:Q ,Female ,Research Article - Abstract
The migration of CD4+ T cells plays an important role in arteriosclerosis obliterans (ASO). However, the molecular mechanisms involved in CD4+ T cell migration are still unclear. The current study is aimed to determine the expression change of miR-142-3p in CD4+ T cells from patients with ASO and investigate its role in CD4+ T cell migration as well the potential mechanisms involved. We identified by qRT-PCR and in situ hybridization that the expression of miR-142-3p in CD4+ T cells was significantly down-regulated in patients with ASO. Chemokine (C-X-C motif) ligand 12 (CXCL12), a common inflammatory chemokine under the ASO condition, was able to down-regulate the expression of miR-142-3p in cultured CD4+ T cells. Up-regulation of miR-142-3p by lentivirus-mediated gene transfer had a strong inhibitory effect on CD4+ T cell migration both in cultured human cells in vitro and in mouse aortas and spleens in vivo. RAC1 and ROCK2 were identified to be the direct target genes in human CD4+ T cells, which are further confirmed by dual luciferase assay. MiR-142-3p had strong regulatory effects on actin cytoskeleton as shown by the actin staining in CD4+ T cells. The results suggest that the expression of miR-142-3p is down-regulated in CD4+ T cells from patients with ASO. The down-regulation of miR-142-3p could increase the migration of CD4+ T cells to the vascular walls by regulation of actin cytoskeleton via its target genes, RAC1 and ROCK2.
- Published
- 2014
16. Application of GFAT as a Novel Selection Marker to Mediate Gene Expression
- Author
-
Ling Lu, Lun Li, Guogan Wu, Weilan Shao, Wei Qu, Yu Sun, and Ying Huang
- Subjects
Applied Microbiology ,lcsh:Medicine ,Gene Expression ,Yeast and Fungal Models ,medicine.disease_cause ,Schizosaccharomyces Pombe ,Gene Knockout Techniques ,Plasmid ,Transduction, Genetic ,Gene Expression Regulation, Fungal ,Gene expression ,Recombinase ,lcsh:Science ,Glucosamine ,Multidisciplinary ,Genetically Modified Organisms ,Biochemistry ,Genetic Engineering ,Research Article ,Biotechnology ,Plasmids ,Bioengineering ,Mycology ,Biology ,Microbiology ,Models, Biological ,Gene Expression Regulation, Enzymologic ,Model Organisms ,Bacterial Proteins ,Schizosaccharomyces ,medicine ,Selection, Genetic ,Gene ,Escherichia coli ,Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) ,Endo-1,4-beta Xylanases ,Dose-Response Relationship, Drug ,Escherichia coli K12 ,Organisms, Genetically Modified ,lcsh:R ,Genetic Complementation Test ,Gene Expression Regulation, Bacterial ,biology.organism_classification ,Molecular biology ,Yeast ,Schizosaccharomyces pombe ,lcsh:Q ,Biomarkers ,Gene Deletion ,Function (biology) - Abstract
The enzyme glutamine: fructose-6-phosphate aminotransferase (GFAT), also known as glucosamine synthase (GlmS), catalyzes the formation of glucosamine-6-phosphate from fructose-6-phosphate and is the first and rate-limiting enzyme of the hexosamine biosynthetic pathway. For the first time, the GFAT gene was proven to possess a function as an effective selection marker for genetically modified (GM) microorganisms. This was shown by construction and analysis of two GFAT deficient strains, E. coli ΔglmS and S. pombe Δgfa1, and the ability of the GFAT encoding gene to mediate plasmid selection. The gfa1 gene of the fission yeast Schizosaccharomyces pombe was deleted by KanMX6-mediated gene disruption and the Cre-loxP marker removal system, and the glmS gene of Escherichia coli was deleted by using λ-Red mediated recombinase system. Both E. coli ΔglmS and S. pombe Δgfa1 could not grow normally in the media without addition of glucosamine. However, the deficiency was complemented by transforming the plasmids that expressed GFAT genes. The xylanase encoding gene, xynA2 from Thermomyces lanuginosus was successfully expressed and secreted by using GFAT as selection marker in S. pombe. Optimal glucosamine concentration for E. coli ΔglmS and S. pombe Δgfa1 growth was determined respectively. These findings provide an effective technique for the construction of GM bacteria without an antibiotic resistant marker, and the construction of GM yeasts to be applied to complex media.
- Published
- 2011
17. Composition and distribution of vegetation in the water level fluctuating zone of the Lantsang cascade reservoir system using UAV multispectral imagery.
- Author
-
Weiwei Jiang, Lun Liu, Henglin Xiao, Song Zhu, Wentao Li, and Ying Liu
- Subjects
Medicine ,Science - Abstract
With the development of a large number of tall dams and large cascade reservoir projects in the Lantsang River Basin, a large water level fluctuating zone (WLFZ) containing cascading reservoirs has formed. This newborn ecosystem is related to the sustainable development of hydropower projects, and has become a new problem to be studied urgently. Taking WLFZs in the Huangdeng, Xiaowan and Nuozhadu Reservoirs in the Lantsang River Basin as study areas, this study used multi-spectral remote-sensing field data obtained with unmanned aerial vehicles (UAVs) to ascertain the species types, coverage, distribution characteristics, dominant species and pioneer species of naturally restored vegetation. The considered data were subjected to UAV data processing, vegetation classification using multi-spectral images and a geographic information system (GIS) terrain-distribution analysis. Results show that: Polygonum Plebeium, Cynodon dactylon, Xanthium sibiricum, Ageratum conyzoides, Eleusine indica, Digitaria sanguinalis and Verbena officinalis are the dominant species of vegetation that could be naturally restored in the WLFZ; the vegetation coverage and the number of species are significantly positively correlated with the age and restoration periods of the WLFZ; the vegetation coverage of each study area increases at first, and then decreases, as a function of elevation; gentle slopes about 0-25°are more suitable for vegetation restoration. This study provides first-hand data on the natural restoration of vegetation in WLFZs, and gives a useful reference for its ecological restoration as a consequence of hydropower cascade development in the Lantsang River Basin. Finally, the study demonstrates that light UAV remote sensing is an attractive choice for investigating vegetation in reservoir WLFZs.
- Published
- 2021
- Full Text
- View/download PDF
18. Minimally invasive unicompartmental knee replacement: Midterm clinical outcome.
- Author
-
Shaoqi Tian, Jiangjun Liu, Wanqing Yuan, Yuanhe Wang, Chengzhi Ha, Lun Liu, Qicai Li, Xu Yang, and Kang Sun
- Subjects
Medicine ,Science - Abstract
The purpose of this study was to explore the midterm clinical outcomes of unicompartmental knee replacement (UKR) for medial knee arthropathy through a minimally invasive approach (MIA).From January 2006 to June 2010, 442 consecutive patients (485 knees) were included in the study. All patients underwent MIA-UKR with the mobile bearing Oxford phrase III prosthesis. The incision was made starting 1 cm medial to the medial pole of the patella and extending distally to the tibial tubercle. Radiographic evaluations include femorotibial angle (FTA) from coronal x-rays and rectified varus deformity angle, while clinical evaluations included Knee Society Score (KSS, clinical score and function score), the Western Ontario and McMaster Universities Arthritis Index (WOMAC) osteoarthritis index and visual analog scale (VAS) for pain. Patients followed-up at 1, 3, 6, 12 months after surgery and each year thereafter.Four hundreds and two patients completed the entire follow-up, 40 patients (45 knees) were lost to follow-up. The average follow-up time was 73.0 ± 1.9 months. The mean length of the incisions was 5.0 ± 0.2 cm. The average FTA decreased from 183.6° ± 5.1° preoperatively to 174.3° ± 4.2° postoperatively, and the mean rectified varus deformity angle was 9.3° ± 1.2°. The KSS clinical score improved from 42.4 ± 2.9 to 92.9 ± 3.8, and the function score improved from 53.5 ± 3.8 to 93.5 ± 4.0. The WOMAC score improved from 47.5 ± 3.1 preoperatively to 12.3 ± 1.5 at the last evaluation. The VAS dropped from 7.8 ± 1.9 preoperatively to 1.6 ± 0.2 postoperatively. All clinical evaluations (KSS, WOMAC, VAS) were significantly different (p < 0.05) from pre and post-operative evaluations. The survival rate was 99.1% at 73 months, and the revision rate was 0.9%.The midterm clinical outcomes of MIA-UKR are satisfactory in a Chinese patient population, which is a good surgical option for patients with medial arthropathy of the knee. However, longer-term follow-up studies should be performed in these patients.
- Published
- 2017
- Full Text
- View/download PDF
19. Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout.
- Author
-
Fu-Shun Yen, Chih-Cheng Hsu, Hsin-Lun Li, James Cheng-Chung Wei, and Chii-Min Hwu
- Subjects
Medicine ,Science - Abstract
ObjectivesAlthough studies have demonstrated the association of hyperuricemia with cardiovascular (CV) diseases, few have explored the effect of urate-lowering therapy (ULT) on the incidence of CV diseases. Therefore, we compared the risks of hospitalized coronary artery disease (CAD), stroke, heart failure (HF), and all-cause mortality between ULT users and nonusers among patients with gout.MethodsWe performed this retrospective cohort study using Taiwan's population-based National Health Insurance Research Database. In total, 5218 patients with gout were included from 2000 to 2012. We compared the incidence rates (IRs) of hospitalized CAD, stroke, HF, and all-cause mortality between ULT users and matched nonusers.ResultsThe IRs of hospitalized stroke were 0.6 and 1.0 per 100 person-years for ULT users and nonusers, respectively, after adjusting for age, sex, residence, comorbidities, and medications. ULT users showed lower adjusted hazard ratios (aHR) for hospitalized stroke (aHR: 0.52, p < 0.001) and all-cause mortality (aHR: 0.6, p = 0.02) than nonusers. Subgroup analyses revealed that uricosuric agents and xanthine oxidase inhibitors were significantly associated with lower risks of hospitalized stroke and all-cause mortality, respectively. The effect of uricosuric agents on the decrease in hospitalized stroke risk indicated a dose-response relationship.ConclusionsOur study showed lower risks of hospitalized stroke and all-cause mortality in ULT users than in nonusers among patients with gout. Therefore, patients with gout may receive ULT to mitigate the risks of hospitalized stroke and mortality.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.